Clinical trials
Phase 2/3 trials in Croatia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 7 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| University Hospital Dubrava | 2 |
| Biohaven Therapeutics Ltd. | 1 |
| Boehringer Ingelheim | 1 |
| Children's Hospital Zagreb | 1 |
| Denovo Biopharma LLC | 1 |
| EMD Serono | 1 |
| EyeBiotech Ltd. | 1 |
| Facet Biotech | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Crohn Disease | 2 |
| Alveolar Bone Loss | 1 |
| Anemia | 1 |
| Anemia, Iron-Deficiency | 1 |
| Carcinoma, Squamous Cell | 1 |
| Catheter-Related Infections | 1 |
| Corneal Edema | 1 |
| Depressive Disorder | 1 |
Trials
Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.